Zhihong Han1, Zhong Zheng2, Kai Tao1, Yanping Yu1, Jinping Wu3, Xiaofei Tian1. 1. Department of Gynecologic Oncology, Shaanxi Provincial Tumor Hospital, Xi'an, China. 2. Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. 3. Department of Gynecology and Obstetrics, 521 Hospital of Norinco Group Xi'an, Xi'an, China.
Abstract
BACKGROUND: High-risk histologic endometrioid carcinomas include poorly differentiated endometrial carcinoma (PDEC), uterine clear cell carcinoma (UCCC), uterine carcinosarcoma (UCS), and uterine papillary serous carcinomas (UPCS). The purpose of this study was to investigate and compare the effect of open surgery and minimally invasive surgery on the prognosis of patients with high-risk endometrial cancer tissue types. METHODS: A retrospective analysis was conducted to investigate 57 UCS or UPCS, 53 UCCC, and 110 PDEC patients receiving initial treatment at the Department of Gynecology in Shaanxi Provincial Tumor hospital and the Affiliated Hospital of Medical College of Xi'an Jiaotong University between February 2010 and January 2015. Prognostic factors were determined using univariate/multivariate analysis, and survival rates were assessed using the Kaplan-Meier method. The Cox regression model was adopted to assess the independent prognostic factors. RESULTS: Two hundred and twenty patients who met the criteria were included in this study. At the end of follow-up period, 94 patients were still alive. Univariate analysis found that the survival time of the patients was related to staging, adjuvant therapy, and surgical approach. Multivariate analysis revealed that surgical approach, staging, pathology, and adjuvant therapy were independent prognostic factors. CONCLUSIONS: Minimally invasive surgery has a shorter survival time compared to open surgery in women with PDEC, UCCC, UCS, and UPCS. Multivariate analysis confirmed that staging, pathological type, surgical approach, and postoperative adjuvant therapy are independent risk factors for prognosis and affect the survival of women with PDEC, UCCC, UCS, and UPCS. 2021 Gland Surgery. All rights reserved.
BACKGROUND: High-risk histologic endometrioid carcinomas include poorly differentiated endometrial carcinoma (PDEC), uterine clear cell carcinoma (UCCC), uterine carcinosarcoma (UCS), and uterine papillary serous carcinomas (UPCS). The purpose of this study was to investigate and compare the effect of open surgery and minimally invasive surgery on the prognosis of patients with high-risk endometrial cancer tissue types. METHODS: A retrospective analysis was conducted to investigate 57 UCS or UPCS, 53 UCCC, and 110 PDEC patients receiving initial treatment at the Department of Gynecology in Shaanxi Provincial Tumor hospital and the Affiliated Hospital of Medical College of Xi'an Jiaotong University between February 2010 and January 2015. Prognostic factors were determined using univariate/multivariate analysis, and survival rates were assessed using the Kaplan-Meier method. The Cox regression model was adopted to assess the independent prognostic factors. RESULTS: Two hundred and twenty patients who met the criteria were included in this study. At the end of follow-up period, 94 patients were still alive. Univariate analysis found that the survival time of the patients was related to staging, adjuvant therapy, and surgical approach. Multivariate analysis revealed that surgical approach, staging, pathology, and adjuvant therapy were independent prognostic factors. CONCLUSIONS: Minimally invasive surgery has a shorter survival time compared to open surgery in women with PDEC, UCCC, UCS, and UPCS. Multivariate analysis confirmed that staging, pathological type, surgical approach, and postoperative adjuvant therapy are independent risk factors for prognosis and affect the survival of women with PDEC, UCCC, UCS, and UPCS. 2021 Gland Surgery. All rights reserved.
Authors: Edward J Tanner; Mario M Leitao; Karuna Garg; Dennis S Chi; Yukio Sonoda; Ginger J Gardner; Richard R Barakat; Elizabeth L Jewell Journal: Gynecol Oncol Date: 2011-09-25 Impact factor: 5.482
Authors: Wui-Jin Koh; Nadeem R Abu-Rustum; Sarah Bean; Kristin Bradley; Susana M Campos; Kathleen R Cho; Hye Sook Chon; Christina Chu; David Cohn; Marta Ann Crispens; Shari Damast; Oliver Dorigo; Patricia J Eifel; Christine M Fisher; Peter Frederick; David K Gaffney; Suzanne George; Ernest Han; Susan Higgins; Warner K Huh; John R Lurain; Andrea Mariani; David Mutch; Christa Nagel; Larissa Nekhlyudov; Amanda Nickles Fader; Steven W Remmenga; R Kevin Reynolds; Todd Tillmanns; Stefanie Ueda; Emily Wyse; Catheryn M Yashar; Nicole R McMillian; Jillian L Scavone Journal: J Natl Compr Canc Netw Date: 2018-02 Impact factor: 11.908
Authors: Amanda Nickles Fader; Leigh G Seamon; Pedro F Escobar; Heidi E Frasure; Laura A Havrilesky; Kristine M Zanotti; Angeles Alvarez Secord; John F Boggess; David E Cohn; Jeffrey M Fowler; Gregory Skafianos; Emma Rossi; Paola A Gehrig Journal: Gynecol Oncol Date: 2012-04-30 Impact factor: 5.482
Authors: Martin Koskas; Marta Jozwiak; Marie Fournier; Ignace Vergote; Hans Trum; Christianne Lok; Frédéric Amant Journal: Eur J Cancer Date: 2016-08-06 Impact factor: 9.162
Authors: Tilley Jenkins Vogel; Abhay Knickerbocker; Chirag A Shah; Melissa A Schiff; Christina Isacson; Rochelle L Garcia; Barbara A Goff Journal: J Gynecol Oncol Date: 2014-11-06 Impact factor: 4.401